Apoxis Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $28.5M

Apoxis General Information

Description

Developer of therapeutics for the treatment of cancer. The company engages in science-based drug discovery and development. It focuses on developing recombinant therapeutics to address unmet medical needs in cancer and autoimmune disease.

Contact Information

Website
www.apoxis.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 22, chemin des Croisettes
  • 1066 Epalinges
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 22, chemin des Croisettes
  • 1066 Epalinges
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Apoxis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 27-Jun-2007 $28.5M Completed Generating Revenue
2. Later Stage VC 25-Jan-2005 Completed Generating Revenue
1. Early Stage VC 03-Apr-2003 $8.6M $8.6M Completed Startup
To view Apoxis’s complete valuation and funding history, request access »

Apoxis Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Banexi Ventures Partners Venture Capital Minority
HealthCap Venture Capital Minority
Novo Nordisk Corporation Minority
To view Apoxis’s complete investors history, request access »

Apoxis FAQs

  • When was Apoxis founded?

    Apoxis was founded in 1999.

  • Where is Apoxis headquartered?

    Apoxis is headquartered in Epalinges, Switzerland.

  • What industry is Apoxis in?

    Apoxis’s primary industry is Drug Discovery.

  • Is Apoxis a private or public company?

    Apoxis is a Private company.

  • What is the current valuation of Apoxis?

    The current valuation of Apoxis is .

  • What is Apoxis’s current revenue?

    The current revenue for Apoxis is .

  • How much funding has Apoxis raised over time?

    Apoxis has raised $21.4M.

  • Who are Apoxis’s investors?

    Banexi Ventures Partners, HealthCap, and Novo Nordisk have invested in Apoxis.

  • When was Apoxis acquired?

    Apoxis was acquired on 27-Jun-2007.

  • Who acquired Apoxis?

    Apoxis was acquired by Topotarget.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process